MedPath

Comparison of the effect of ropivacaine and ketamine on pain control after cholecystectomy

Phase 3
Recruiting
Conditions
Cholecystitis.
Cholecystitis
Registration Number
IRCT20220411054499N1
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Age 18-60 years old
Patients indicated for laparoscopic cholecystectomy
All patients with a VAS score equal or greater than 5

Exclusion Criteria

Hypersensitivity to Ketamine or Ropivacaine
Has cardiovascular, lung or mental illness
Arbitrary use of any additional painkillers after surgery
Patients indicated for open cholecystectomy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patients' pain based on visual analog scale. Timepoint: 2, 4, 8, 12, 24 hours after surgery. Method of measurement: Use visual analog scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath